Dr Agarwal's Health Care Posts Strong Q3, Eyes Ethiopia Expansion

OTHER
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Dr Agarwal's Health Care Posts Strong Q3, Eyes Ethiopia Expansion
Overview

Dr. Agarwal's Health Care Limited announced robust unaudited consolidated financial results for Q3 FY2026. Revenue from operations grew 23.0% YoY to INR 530 Cr, while Profit After Tax (PAT) surged 54.5% YoY to INR 44 Cr. The company also expanded its network to 272 facilities and announced plans for an international subsidiary in Ethiopia.

📉 The Financial Deep Dive

The company demonstrated robust financial performance for Q3 FY2026 compared to the prior year.

  • Revenue: Revenue from Operations grew by 23.0% YoY to INR 530 Cr, with Total Income rising 21.8% YoY to INR 540 Cr.
  • Profitability: EBITDA increased by 21.3% YoY to INR 155 Cr, maintaining healthy EBITDA margins at 28.6%. Profit After Tax (PAT) surged by a significant 54.5% YoY to INR 44 Cr, with PAT margins improving to 8.1%.
  • Nine-Month Performance: For the first nine months of FY2026 (9M FY2026), Total Income was INR 1,548 Cr (+20.8% YoY), Revenue from Operations was INR 1,516 Cr (+21.2% YoY), EBITDA reached INR 440 Cr (+23.6% YoY) with margins at 28.4%, and PAT saw a substantial 74.3% YoY increase to INR 118 Cr (margins at 7.6%).

📈 Operational Highlights & Growth Drivers

Operationally, the company continues its expansion trajectory.

  • The network expanded to 272 facilities, with 14 new centers added in Q3 FY2026.
  • Surgeries performed increased by 11.2% YoY to 81,002 in the quarter, indicating strong demand for services.

🌍 Strategy & Outlook

Management expressed confidence in meeting annual guidance, attributing growth to resilient demand and strong momentum in expansion plans. Key growth drivers include:

  • Greenfield Expansion: Plans for establishing new facilities.
  • Geographic Deepening: Strengthening presence in existing and new geographies.
  • International Foray: A significant strategic move involves incorporating a wholly-owned subsidiary in Ethiopia through its Mauritius subsidiary, Orbit Healthcare Services (Mauritius) Limited.
  • Corporate Restructuring: Idearx Services Private Limited will cease to be an Associate company, although Dr. Agarwal's Health Care Limited will retain a 14.54% equity stake. The registered office is also set to shift within Chennai.

The consistent YoY growth across key financial metrics, coupled with aggressive network expansion and international ambition, positions the company for continued upward trajectory. Investors will watch the execution of the Ethiopia subsidiary and the impact of new center additions.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.